Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples